Thiotepa Production Cost Reports

The report provides a detailed analysis essential for establishing a Thiotepa production plant. It encompasses all critical aspects necessary for Thiotepa production, including the cost of Thiotepa production, Thiotepa plant cost, Thiotepa production costs, and the overall Thiotepa production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Thiotepa production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Thiotepa is an alkylating agent that is used as an anti-cancer medication. It works by damaging the DNA and RNA of cancer cells, which prevents their growth and multiplication. It is used in combination with other chemotherapy agents to treat various cancers like breast cancer, ovarian cancer, bladder cancer, and haematological tumours like Hodgkin’s lymphoma and leukaemia. It is also used as a conditioning agent before allogeneic or autologous hematopoietic progenitor cell transplantation (HPCT) to prepare patients for stem cell or bone marrow transplants. It is employed in palliative care to control malignant effusions caused by metastatic cancers. It is administered by intravenous infusion and intravesical treatments for bladder cancer. Its ability to penetrate brain capillaries makes it useful for be used in treatment of certain brain tumours and leptomeningeal metastases.

The Thiotepa market is influenced by its important role in treating haematological malignancies and its use as a conditioning agent in hematopoietic stem cell transplantation (HSCT) procedures. The growing incidence of cancers like breast, bladder, ovarian, and blood cancers significantly fuels its demand. The rising number of bone marrow transplants and advancements in transplantation techniques further contribute to its demand. Also, innovations in drug delivery systems (like rapid intravenous infusion, intracavitary injection, and intravesical instillation) and combination therapies expand their utilisation. Industrial Thiotepa procurement is affected by regulatory approvals, production capacity, availability of raw materials, competition from generic drugs, etc.

Raw Material for Thiotepa Production

According to the Thiotepa production plant project report, the key raw materials used in the production of Thiotepa include Ethylenimine-Thiophosphoryl Chloride-Triethylamine-Potassium Carbonate.

Production Process of Thiotepa

The extensive Thiotepa production cost report consists of the following major industrial production process:

1. From Ethylenimine and Thiophosphoryl Chloride: The production of involves a reaction between ethylenimine and thiophosphoryl chloride. This reaction takes place in the presence of triethylamine as a base and dry benzene as the solvent. The reaction takes place at controlled low temperatures where thiophosphoryl chloride is added dropwise together with an acid-binding agent (a mixture of potassium carbonate and triethylamine) to neutralise released hydrochloric acid. After this, the reaction mixture is filtered, and the solvent is evaporated under reduced pressure. The crude product is purified to get pure Thiotepa as the final product.

Thiotepa has a molecular formula of C6H12N3PS and a molecular weight of 189.22 g/mol. It appears as a white crystalline solid with a melting point of 51.5 degree Celsius. It contains three aziridine (ethyleneimine) rings attached to a phosphine sulfide group, which makes it a polyfunctional alkylating agent. It is moderately soluble in water and has an octanol-water partition coefficient (log P) of 0.53, which makes it moderately lipophilic. It is chemically reactive and goes through solvolysis and degradation under acidic conditions to form derivatives like tepa. It is stable in alkaline medium but degrades quicker in acidic conditions. All these physical and chemical properties contribute to its pharmacological activity and stability.